Cargando…
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
OBJECTIVE: Plasma osteoprotegerin (P-OPG) is an independent predictor of cardiovascular disease in diabetic and other populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells and increased P-OPG may reflect arterial damage. We investigated the correlation between P-OP...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162489/ https://www.ncbi.nlm.nih.gov/pubmed/21801376 http://dx.doi.org/10.1186/1475-2840-10-70 |
_version_ | 1782210813303455744 |
---|---|
author | Reinhard, Henrik Nybo, Mads Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rasmussen, Lars M Rossing, Peter Jacobsen, Peter K |
author_facet | Reinhard, Henrik Nybo, Mads Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rasmussen, Lars M Rossing, Peter Jacobsen, Peter K |
author_sort | Reinhard, Henrik |
collection | PubMed |
description | OBJECTIVE: Plasma osteoprotegerin (P-OPG) is an independent predictor of cardiovascular disease in diabetic and other populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells and increased P-OPG may reflect arterial damage. We investigated the correlation between P-OPG and coronary artery disease (CAD) in asymptomatic type 2 diabetic patients with microalbuminuria. METHODS: P-OPG was measured in 200 asymptomatic diabetic patients without known cardiac disease. Patients with P-NT-proBNP >45.2 ng/l and/or coronary calcium score (CCS) ≥400 were stratified as high risk of CAD (n = 133), and all other patients as low risk patients (n = 67). High risk patients were examined by myocardial perfusion imaging (MPI; n = 109), and/or CT-angiography (n = 20), and/or coronary angiography (CAG; n = 86). Significant CAD was defined by presence of significant myocardial perfusion defects at MPI and/or >70% coronary artery stenosis at CAG. RESULTS: Significant CAD was demonstrated in 70 of the high risk patients and of these 23 patients had >70% coronary artery stenosis at CAG. Among high risk patients, increased P-OPG was an independent predictor of significant CAD (adjusted odds ratio [CI] 3.11 [1.01-19.54] and 3.03 [1.00-9.18] for second and third tertile vs.first tertile P-OPG, respectively) and remained so after adjustments for NT-proBNP and CCS. High P-OPG was also associated with presence of >70% coronary artery stenosis(adjusted odds ratio 14.20 [1.35-148.92] for third vs. first tertile P-OPG), and 91% of patients with low (first tertile) P-OPG did not have >70% coronary artery stenosis. CONCLUSIONS: Elevated P-OPG is an independent predictor of the presence of CAD in asymptomatic type 2 diabetic patients with microalbuminuria. |
format | Online Article Text |
id | pubmed-3162489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31624892011-08-27 Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria Reinhard, Henrik Nybo, Mads Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rasmussen, Lars M Rossing, Peter Jacobsen, Peter K Cardiovasc Diabetol Original Investigation OBJECTIVE: Plasma osteoprotegerin (P-OPG) is an independent predictor of cardiovascular disease in diabetic and other populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells and increased P-OPG may reflect arterial damage. We investigated the correlation between P-OPG and coronary artery disease (CAD) in asymptomatic type 2 diabetic patients with microalbuminuria. METHODS: P-OPG was measured in 200 asymptomatic diabetic patients without known cardiac disease. Patients with P-NT-proBNP >45.2 ng/l and/or coronary calcium score (CCS) ≥400 were stratified as high risk of CAD (n = 133), and all other patients as low risk patients (n = 67). High risk patients were examined by myocardial perfusion imaging (MPI; n = 109), and/or CT-angiography (n = 20), and/or coronary angiography (CAG; n = 86). Significant CAD was defined by presence of significant myocardial perfusion defects at MPI and/or >70% coronary artery stenosis at CAG. RESULTS: Significant CAD was demonstrated in 70 of the high risk patients and of these 23 patients had >70% coronary artery stenosis at CAG. Among high risk patients, increased P-OPG was an independent predictor of significant CAD (adjusted odds ratio [CI] 3.11 [1.01-19.54] and 3.03 [1.00-9.18] for second and third tertile vs.first tertile P-OPG, respectively) and remained so after adjustments for NT-proBNP and CCS. High P-OPG was also associated with presence of >70% coronary artery stenosis(adjusted odds ratio 14.20 [1.35-148.92] for third vs. first tertile P-OPG), and 91% of patients with low (first tertile) P-OPG did not have >70% coronary artery stenosis. CONCLUSIONS: Elevated P-OPG is an independent predictor of the presence of CAD in asymptomatic type 2 diabetic patients with microalbuminuria. BioMed Central 2011-07-29 /pmc/articles/PMC3162489/ /pubmed/21801376 http://dx.doi.org/10.1186/1475-2840-10-70 Text en Copyright ©2011 Reinhard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Investigation Reinhard, Henrik Nybo, Mads Hansen, Peter R Wiinberg, Niels Kjær, Andreas Petersen, Claus L Winther, Kaj Parving, Hans-Henrik Rasmussen, Lars M Rossing, Peter Jacobsen, Peter K Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title_full | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title_fullStr | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title_full_unstemmed | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title_short | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
title_sort | osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162489/ https://www.ncbi.nlm.nih.gov/pubmed/21801376 http://dx.doi.org/10.1186/1475-2840-10-70 |
work_keys_str_mv | AT reinhardhenrik osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT nybomads osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT hansenpeterr osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT wiinbergniels osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT kjærandreas osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT petersenclausl osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT wintherkaj osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT parvinghanshenrik osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT rasmussenlarsm osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT rossingpeter osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria AT jacobsenpeterk osteoprotegerinandcoronaryarterydiseaseintype2diabeticpatientswithmicroalbuminuria |